Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases

Atrial Flutter Clinical Trials

A listing of Atrial Flutter medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


Georgia

Emory University Hospital Midtown
Atlanta Georgia 30308

A clinical trial seeking patients for a research study for the treatment of Cardiac Catheter Ablation, Atrial Flutter or Cardiac Arrhythmias

Emory University Hospital
Atlanta Georgia 30322

A clinical trial to evaluate treatments using Catheter ablation for patients with Atrial Flutter or Arrhythmia

Michigan

Sparrow Clinical Research Institute
Lansing Michigan 48912

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nebraska

Bryan Heart
Lincoln Nebraska 68506

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Ohio

The Ohio State University Medical Center
Columbus Ohio 43210

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pennsylvania

Berks Cardiologists, Ltd.
Wyomissing Pennsylvania 19610

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Tennessee

The Jackson Clinic, PA
Jackson Tennessee 38305

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Vanderbilt University Medical Center
Nashville Tennessee 37232

A clinical research study of dabigatran etexilate mesylate for the treatment of Atrial Fibrillation or Atrial Flutter

Bulgaria

Sofia 1309
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Varna 9010
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Canada

London Health Sciences Center
London Ontario N6A 5A5

A clinical trial to evaluate treatments using tricuspid isthmus imaging with Cartosound for patients with Atrial Flutter

France

Creteil 94010
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

CHU Grenoble
Grenoble 38000

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

CHU de Rennes
Rennes 35033

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

University Hospital of Rouen
Rouen 76000

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

CHU de Saint-Etienne
Saint-etienne 42 055

A clinical trial to evaluate treatments using Ramipril and Placebo for patients with Atrial Fibrillation or Atrial Flutter

View More »

Clinique Pasteur
Toulouse 31076

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Germany

Universitiy Medical Centre Rostock
Rostock 18057

A clinical research study of Antiarrhythmic drug, Cavo-tricuspid-isthmus-ablation and Pulmonary vein isolation for the treatment of Atrial Fibrillation or Atrial Flutter

Poland

Krakow 31-121
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lodz 91-347
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lublin 20-954
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Wroclaw 50-420
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Turkey

Istanbul
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Istanbul 34662
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Samsun 55139
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Ukraine

Donetsk 83045
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Kiev 03680
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Uzhhorod 88000
Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation